110 related articles for article (PubMed ID: 12032772)
21. MYSM1/miR-150/FLT3 inhibits B1a cell proliferation.
Jiang XX; Liu Y; Li H; Gao Y; Mu R; Guo J; Zhang J; Yang YM; Xiao F; Liu B; Wang C; Shen B; Chen SY; Li Z; Yang G
Oncotarget; 2016 Oct; 7(42):68086-68096. PubMed ID: 27590507
[TBL] [Abstract][Full Text] [Related]
22. Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.
Abbaspour Babaei M; Kamalidehghan B; Saleem M; Huri HZ; Ahmadipour F
Drug Des Devel Ther; 2016; 10():2443-59. PubMed ID: 27536065
[TBL] [Abstract][Full Text] [Related]
23. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics.
Stabile C; Taglia I; Battisti C; Bianchi S; Federico A
Neurol Sci; 2016 Sep; 37(9):1565-9. PubMed ID: 27338940
[TBL] [Abstract][Full Text] [Related]
24. BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment.
Soliman A; Aal AA; Afify R; Ibrahim N
Open Access Maced J Med Sci; 2016 Jun; 4(2):264-70. PubMed ID: 27335598
[TBL] [Abstract][Full Text] [Related]
25. Quantitative phosphotyrosine profiling of patient-derived xenografts identifies therapeutic targets in pediatric leukemia.
Dolai S; Sia KC; Robbins AK; Zhong L; Heatley SL; Vincent TL; Hochgräfe F; Sutton R; Kurmasheva RT; Revesz T; White DL; Houghton PJ; Smith MA; Teachey DT; Daly RJ; Raftery MJ; Lock RB
Cancer Res; 2016 May; 76(9):2766-2777. PubMed ID: 26960974
[TBL] [Abstract][Full Text] [Related]
26. A systems-level interrogation identifies regulators of Drosophila blood cell number and survival.
Sopko R; Lin YB; Makhijani K; Alexander B; Perrimon N; Brückner K
PLoS Genet; 2015 Mar; 11(3):e1005056. PubMed ID: 25749252
[TBL] [Abstract][Full Text] [Related]
27. Drosophila as a model for the two myeloid blood cell systems in vertebrates.
Gold KS; Brückner K
Exp Hematol; 2014 Aug; 42(8):717-27. PubMed ID: 24946019
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the antitumor effects of BPR1J-340, a potent and selective FLT3 inhibitor, alone or in combination with an HDAC inhibitor, vorinostat, in AML cancer.
Lin WH; Yeh TK; Jiaang WT; Yen KJ; Chen CH; Huang CT; Yen SC; Hsieh SY; Chou LH; Chen CP; Chiu CH; Kao LC; Chao YS; Chen CT; Hsu JT
PLoS One; 2014; 9(1):e83160. PubMed ID: 24416160
[TBL] [Abstract][Full Text] [Related]
29. CSF1R mutations in hereditary diffuse leukoencephalopathy with spheroids are loss of function.
Pridans C; Sauter KA; Baer K; Kissel H; Hume DA
Sci Rep; 2013 Oct; 3():3013. PubMed ID: 24145216
[TBL] [Abstract][Full Text] [Related]
30. Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date.
Lowe EJ; Lim MS
Paediatr Drugs; 2013 Jun; 15(3):163-9. PubMed ID: 23696342
[TBL] [Abstract][Full Text] [Related]
31. BPR1J-097, a novel FLT3 kinase inhibitor, exerts potent inhibitory activity against AML.
Lin WH; Jiaang WT; Chen CW; Yen KJ; Hsieh SY; Yen SC; Chen CP; Chang KY; Chang CY; Chang TY; Huang YL; Yeh TK; Chao YS; Chen CT; Hsu JT
Br J Cancer; 2012 Jan; 106(3):475-81. PubMed ID: 22187040
[TBL] [Abstract][Full Text] [Related]
32. Online nanoflow multidimensional fractionation for high efficiency phosphopeptide analysis.
Ficarro SB; Zhang Y; Carrasco-Alfonso MJ; Garg B; Adelmant G; Webber JT; Luckey CJ; Marto JA
Mol Cell Proteomics; 2011 Nov; 10(11):O111.011064. PubMed ID: 21788404
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic tyrosine kinases target Dok-1 for ubiquitin-mediated proteasomal degradation to promote cell transformation.
Janas JA; Van Aelst L
Mol Cell Biol; 2011 Jul; 31(13):2552-65. PubMed ID: 21536658
[TBL] [Abstract][Full Text] [Related]
34. mTOR signaling is activated by FLT3 kinase and promotes survival of FLT3-mutated acute myeloid leukemia cells.
Chen W; Drakos E; Grammatikakis I; Schlette EJ; Li J; Leventaki V; Staikou-Drakopoulou E; Patsouris E; Panayiotidis P; Medeiros LJ; Rassidakis GZ
Mol Cancer; 2010 Nov; 9():292. PubMed ID: 21067588
[TBL] [Abstract][Full Text] [Related]
35. Global dynamics of hematopoietic stem cells and differentiated cells in a chronic myeloid leukemia model.
Aïnseba B; Benosman C
J Math Biol; 2011 Jun; 62(6):975-97. PubMed ID: 20717678
[TBL] [Abstract][Full Text] [Related]
36. Fms-like tyrosine kinase 3 ligand decreases T helper type 17 cells and suppressors of cytokine signaling proteins in the lung of house dust mite-sensitized and -challenged mice.
McGee HS; Stallworth AL; Agrawal T; Shao Z; Lorence L; Agrawal DK
Am J Respir Cell Mol Biol; 2010 Nov; 43(5):520-9. PubMed ID: 19933379
[TBL] [Abstract][Full Text] [Related]
37. Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice.
McGee HS; Edwan JH; Agrawal DK
Am J Respir Cell Mol Biol; 2010 Mar; 42(3):331-40. PubMed ID: 19448155
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a direct involvement of hMSH5 in promoting ionizing radiation induced apoptosis.
Tompkins JD; Wu X; Chu YL; Her C
Exp Cell Res; 2009 Aug; 315(14):2420-32. PubMed ID: 19442657
[TBL] [Abstract][Full Text] [Related]
39. STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner.
Sims JT; Ganguly S; Fiore LS; Holler CJ; Park ES; Plattner R
Biochem Pharmacol; 2009 Aug; 78(3):249-60. PubMed ID: 19427998
[TBL] [Abstract][Full Text] [Related]
40. Reciprocal regulation of Abl and receptor tyrosine kinases.
Srinivasan D; Kaetzel DM; Plattner R
Cell Signal; 2009 Jul; 21(7):1143-50. PubMed ID: 19275932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
